AI assistant
Denali Therapeutics Inc. — Director's Dealing 2021
Sep 17, 2021
31637_dirs_2021-09-17_dd8350b9-ef3c-4a49-beb6-9873f05be651.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Denali Therapeutics Inc. (DNLI)
CIK: 0001714899
Period of Report: 2021-09-15
Reporting Person: SATO VICKI L (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-09-15 | Common Stock | S | 230 | $52.28 | Disposed | 130935 | Direct |
| 2021-09-15 | Common Stock | S | 676 | $53.03 | Disposed | 130259 | Direct |
| 2021-09-15 | Common Stock | S | 620 | $53.92 | Disposed | 129639 | Direct |
| 2021-09-15 | Common Stock | S | 140 | $54.76 | Disposed | 129499 | Direct |
Footnotes
F1: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan.
F2: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $51.56 to $52.55 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
F3: Includes 2,074 restricted stock units.
F4: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $52.56 to $53.48 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
F5: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $53.57 to $54.55 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
F6: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $54.63 to $54.89 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.